1.53% -0.0479

Nrx Pharmaceuticals Inc (NRXP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Income/Loss From Continuing Operations Before Tax	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Net Income/Loss	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$35.83

1.66%

INCY

$85.75

1.10%

GMAB

$31.46

2.62%

BNTX

$102.62

4.05%

INSM

$144.22

0.15%

ONC

$342.98

0.67%